Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07097974

Evaluation of the Efficacy of the Composite WM Formula in Body Weight Change

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
TCI Co., Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate the effects of the combined formula WM Formula, used as a dietary supplement, with a focus on improvements in glycemic and lipid parameters, body composition, and gut microbiota profiles.

Detailed description

This study is a single-center, randomized, double-blind, placebo-controlled human clinical trial designed to evaluate the potential effect of the WM Formula composite supplement on body weight. Eligible participants will be adults aged 18 years or older, screened based on waist circumference or body fat percentage. Participants will be randomly assigned to one of two groups: one receiving the combined formula WM Formula, and the other receiving a placebo. Each group will take either the WM Formula or placebo, and undergo regular assessments throughout the 4-week study period. Physiological parameters (e.g., height, weight, blood pressure, BMI) and biochemical markers (including liver and kidney function, lipid profile, and blood glucose levels) will be collected at baseline (Week 0), Week 2, and Week 4. In addition, participants will complete appetite assessment questionnaires and other surveys to evaluate changes in appetite and gastrointestinal symptoms.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWM formula liquid drinkOne glass jar (50 g) of the WM formula liquid drink was administered once daily, 1 hour prior to the first meal of the day.
DIETARY_SUPPLEMENTPlaceboOne glass jar (50 g) of the placebo liquid drink was administered once daily, 1 hour prior to the first meal of the day.

Timeline

Start date
2025-08-31
Primary completion
2025-11-30
Completion
2025-12-31
First posted
2025-08-01
Last updated
2025-08-01

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07097974. Inclusion in this directory is not an endorsement.